109 related articles for article (PubMed ID: 21362226)
1. [Significance of methylation status of zo-1 gene in differential diagnosis for myelodysplastic syndrome].
Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):76-80. PubMed ID: 21362226
[TBL] [Abstract][Full Text] [Related]
2. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression].
Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):746-9. PubMed ID: 26117030
[TBL] [Abstract][Full Text] [Related]
4. [ZO-1 gene methylation status and its clinical significance in children with non-Hodgkin lymphoma].
Diao YQ; Qu F; Yang MJ; Meng JH; Zhu XL; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jun; 16(6):619-23. PubMed ID: 24927439
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Significance of ID4 Gene Mehtylation in Demethylation-Treated MDS Cell Line and 2 MDS Patients].
Kang HY; Wang XR; Gao L; Wang W; Li MY; Wang LL; Wang CB; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):455-9. PubMed ID: 25948204
[TBL] [Abstract][Full Text] [Related]
6. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
[TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.
Yang Y; Zhang Q; Xu F; Chang C; Li X
Eur J Haematol; 2012 Dec; 89(6):469-77. PubMed ID: 23005040
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of zo-1 and id4 gene abnormal methylation in multiple myeloma].
Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1192-7. PubMed ID: 21129259
[TBL] [Abstract][Full Text] [Related]
10. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Detection of ID4 Gene Aberrant Methylation in the Differentiation of Myelodysplastic Syndrome from Aplastic Anemia.
Li MY; Xu YY; Kang HY; Wang XR; Gao L; Cen J; Wang W; Wang N; Li YH; Wang LL; Yu L
Chin Med J (Engl); 2015 Aug; 128(15):2019-25. PubMed ID: 26228212
[TBL] [Abstract][Full Text] [Related]
13. Methylation status of fragile histidine triad (FHIT) gene and its clinical impact on prognosis of patients with myelodysplastic syndrome.
Lin J; Yao DM; Qian J; Wang YL; Han LX; Jiang YW; Fei X; Cen JN; Chen ZX
Leuk Res; 2008 Oct; 32(10):1541-5. PubMed ID: 18367246
[TBL] [Abstract][Full Text] [Related]
14. Prognostic relevance of aberrant SOCS-1 gene promoter methylation in myelodysplastic syndromes patients.
Chaubey R; Sazawal S; Mahapatra M; Chhikara S; Saxena R
Int J Lab Hematol; 2015 Apr; 37(2):265-71. PubMed ID: 25123164
[TBL] [Abstract][Full Text] [Related]
15. Methylation of Wnt antagonist genes: a useful prognostic marker for myelodysplastic syndrome.
Wang H; Fan R; Wang XQ; Wu DP; Lin GW; Xu Y; Li WY
Ann Hematol; 2013 Jan; 92(2):199-209. PubMed ID: 23093371
[TBL] [Abstract][Full Text] [Related]
16. Aberrant hypermethylation of CTNNA1 gene is associated with higher IPSS risk in patients with myelodysplastic syndrome.
Qian J; Chen XX; Qian W; Yang J; Wen XM; Ma JC; Deng ZQ; Qian Z; Zhang YY; Lin J
Clin Chem Lab Med; 2014 Dec; 52(12):1859-65. PubMed ID: 25153418
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary study on difference of Id4 gene methylation in various types of myelodysplastic syndromes].
Zhao Y; Bo J; Dou LP; Jing Y; Wang SH; Wang QS; Li HH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):618-20. PubMed ID: 19549375
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
Feng BZ; Lei JL; Han JZ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
[TBL] [Abstract][Full Text] [Related]
20. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]